An impending crisis looms over India's supply of injectable poliomyelitis vaccine (IPV) as French drugmaker Sanofi has shut down its manufacturing plants in the country, halting production of its IPV brand ShanIPV in December 2023. Sanofi's closure has raised concerns about disruptions in India's polio eradication efforts, as it catered to over 80% of the country's IPV dose requirements. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
